Daiichi Sankyo Files First Home-Developed mRNA COVID Vaccine in Japan

Daiichi Sankyo said on January 13 that it has applied for Japan approval for its mRNA COVID-19 vaccine DS-5670, the first of its kind to be developed in the country, on the same day. The jab is intended to be...read more